3-38946916-CA-CAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001349253.2(SCN11A):​c.268-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00951 in 1,486,338 control chromosomes in the GnomAD database, including 82 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0071 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0098 ( 74 hom. )

Consequence

SCN11A
NM_001349253.2 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.515

Publications

0 publications found
Variant links:
Genes affected
SCN11A (HGNC:10583): (sodium voltage-gated channel alpha subunit 11) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is highly expressed in nociceptive neurons of dorsal root ganglia and trigeminal ganglia. It mediates brain-derived neurotrophic factor-evoked membrane depolarization and is a major effector of peripheral inflammatory pain hypersensitivity. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy type VII and familial episodic pain syndrome-3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
SCN11A Gene-Disease associations (from GenCC):
  • autosomal dominant hereditary sensory and autonomic neuropathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • familial episodic pain syndrome with predominantly lower limb involvement
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary sensory and autonomic neuropathy type 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 3-38946916-C-CA is Benign according to our data. Variant chr3-38946916-C-CA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00705 (1068/151408) while in subpopulation NFE AF = 0.0124 (843/67784). AF 95% confidence interval is 0.0117. There are 8 homozygotes in GnomAd4. There are 498 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1068 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN11ANM_001349253.2 linkc.268-10dupT intron_variant Intron 5 of 29 ENST00000302328.9 NP_001336182.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN11AENST00000302328.9 linkc.268-10_268-9insT intron_variant Intron 5 of 29 5 NM_001349253.2 ENSP00000307599.3 Q9UI33-1

Frequencies

GnomAD3 genomes
AF:
0.00706
AC:
1068
AN:
151290
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00158
Gnomad AMI
AF:
0.00664
Gnomad AMR
AF:
0.00342
Gnomad ASJ
AF:
0.00693
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.00125
Gnomad FIN
AF:
0.00570
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.00530
GnomAD2 exomes
AF:
0.00772
AC:
1671
AN:
216350
AF XY:
0.00785
show subpopulations
Gnomad AFR exome
AF:
0.00164
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00676
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00586
Gnomad NFE exome
AF:
0.0128
Gnomad OTH exome
AF:
0.00844
GnomAD4 exome
AF:
0.00979
AC:
13070
AN:
1334930
Hom.:
74
Cov.:
20
AF XY:
0.00975
AC XY:
6518
AN XY:
668690
show subpopulations
African (AFR)
AF:
0.00189
AC:
56
AN:
29626
American (AMR)
AF:
0.00209
AC:
77
AN:
36786
Ashkenazi Jewish (ASJ)
AF:
0.00700
AC:
170
AN:
24278
East Asian (EAS)
AF:
0.000283
AC:
11
AN:
38896
South Asian (SAS)
AF:
0.00226
AC:
178
AN:
78812
European-Finnish (FIN)
AF:
0.00627
AC:
332
AN:
52912
Middle Eastern (MID)
AF:
0.00110
AC:
6
AN:
5456
European-Non Finnish (NFE)
AF:
0.0116
AC:
11746
AN:
1012378
Other (OTH)
AF:
0.00886
AC:
494
AN:
55786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
592
1185
1777
2370
2962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00705
AC:
1068
AN:
151408
Hom.:
8
Cov.:
33
AF XY:
0.00673
AC XY:
498
AN XY:
73980
show subpopulations
African (AFR)
AF:
0.00157
AC:
65
AN:
41300
American (AMR)
AF:
0.00341
AC:
52
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00693
AC:
24
AN:
3464
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5164
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4808
European-Finnish (FIN)
AF:
0.00570
AC:
59
AN:
10358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0124
AC:
843
AN:
67784
Other (OTH)
AF:
0.00524
AC:
11
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
54
108
163
217
271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0118
Hom.:
5
Bravo
AF:
0.00642

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN11A: BS1, BS2 -

Feb 28, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

SCN11A-related disorder Benign:1
Feb 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hereditary sensory and autonomic neuropathy type 7;C3809899:Familial episodic pain syndrome with predominantly lower limb involvement Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552650164; hg19: chr3-38988407; COSMIC: COSV100182863; API